rs35366573

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_172351.3(CD46):​c.1013C>T​(p.Ala338Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0172 in 1,610,994 control chromosomes in the GnomAD database, including 392 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A338A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.014 ( 39 hom., cov: 32)
Exomes 𝑓: 0.018 ( 353 hom. )

Consequence

CD46
NM_172351.3 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -4.38

Publications

51 publications found
Variant links:
Genes affected
CD46 (HGNC:6953): (CD46 molecule) The protein encoded by this gene is a type I membrane protein and is a regulatory part of the complement system. The encoded protein has cofactor activity for inactivation of complement components C3b and C4b by serum factor I, which protects the host cell from damage by complement. In addition, the encoded protein can act as a receptor for the Edmonston strain of measles virus, human herpesvirus-6, and type IV pili of pathogenic Neisseria. Finally, the protein encoded by this gene may be involved in the fusion of the spermatozoa with the oocyte during fertilization. Mutations at this locus have been associated with susceptibility to hemolytic uremic syndrome. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jun 2010]
MIR29B2CHG (HGNC:32018): (MIR29B2 and MIR29C host gene)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002087295).
BP6
Variant 1-207785101-C-T is Benign according to our data. Variant chr1-207785101-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 294975.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0142 (2166/152200) while in subpopulation NFE AF = 0.0191 (1298/67998). AF 95% confidence interval is 0.0182. There are 39 homozygotes in GnomAd4. There are 1123 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 39 AD,SD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_172351.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CD46
NM_172351.3
MANE Select
c.1013C>Tp.Ala338Val
missense
Exon 10 of 13NP_758861.1P15529-11
CD46
NM_172359.3
c.1058C>Tp.Ala353Val
missense
Exon 11 of 13NP_758869.1P15529-2
CD46
NM_002389.4
c.1058C>Tp.Ala353Val
missense
Exon 11 of 14NP_002380.3P15529-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CD46
ENST00000367042.6
TSL:1 MANE Select
c.1013C>Tp.Ala338Val
missense
Exon 10 of 13ENSP00000356009.1P15529-11
CD46
ENST00000322875.8
TSL:1
c.1058C>Tp.Ala353Val
missense
Exon 11 of 13ENSP00000313875.4P15529-2
CD46
ENST00000358170.6
TSL:1
c.1058C>Tp.Ala353Val
missense
Exon 11 of 14ENSP00000350893.2P15529-1

Frequencies

GnomAD3 genomes
AF:
0.0142
AC:
2166
AN:
152082
Hom.:
39
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00268
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00380
Gnomad ASJ
AF:
0.00922
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.0607
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0191
Gnomad OTH
AF:
0.00909
GnomAD2 exomes
AF:
0.0151
AC:
3782
AN:
250790
AF XY:
0.0151
show subpopulations
Gnomad AFR exome
AF:
0.00228
Gnomad AMR exome
AF:
0.00180
Gnomad ASJ exome
AF:
0.00795
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0586
Gnomad NFE exome
AF:
0.0196
Gnomad OTH exome
AF:
0.0118
GnomAD4 exome
AF:
0.0176
AC:
25611
AN:
1458794
Hom.:
353
Cov.:
29
AF XY:
0.0171
AC XY:
12433
AN XY:
725836
show subpopulations
African (AFR)
AF:
0.00227
AC:
76
AN:
33424
American (AMR)
AF:
0.00235
AC:
105
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
0.00762
AC:
199
AN:
26110
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39662
South Asian (SAS)
AF:
0.00165
AC:
142
AN:
86146
European-Finnish (FIN)
AF:
0.0553
AC:
2950
AN:
53370
Middle Eastern (MID)
AF:
0.000520
AC:
3
AN:
5764
European-Non Finnish (NFE)
AF:
0.0193
AC:
21425
AN:
1109338
Other (OTH)
AF:
0.0118
AC:
711
AN:
60280
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
1068
2136
3204
4272
5340
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
780
1560
2340
3120
3900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0142
AC:
2166
AN:
152200
Hom.:
39
Cov.:
32
AF XY:
0.0151
AC XY:
1123
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.00267
AC:
111
AN:
41528
American (AMR)
AF:
0.00379
AC:
58
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00922
AC:
32
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4822
European-Finnish (FIN)
AF:
0.0607
AC:
643
AN:
10588
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0191
AC:
1298
AN:
67998
Other (OTH)
AF:
0.00900
AC:
19
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
111
222
334
445
556
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0172
Hom.:
112
Bravo
AF:
0.0102
TwinsUK
AF:
0.0218
AC:
81
ALSPAC
AF:
0.0192
AC:
74
ESP6500AA
AF:
0.00295
AC:
13
ESP6500EA
AF:
0.0173
AC:
149
ExAC
AF:
0.0149
AC:
1805
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.0162
EpiControl
AF:
0.0169

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not specified (3)
-
-
2
Atypical hemolytic-uremic syndrome (2)
-
-
2
Atypical hemolytic-uremic syndrome with MCP/CD46 anomaly (2)
-
-
2
not provided (2)
-
-
1
Myofibrillar myopathy 6 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.63
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
0.034
DANN
Benign
0.52
DEOGEN2
Benign
0.11
T
Eigen
Benign
-2.1
Eigen_PC
Benign
-2.2
FATHMM_MKL
Benign
0.0043
N
LIST_S2
Benign
0.63
T
MetaRNN
Benign
0.0021
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.77
N
PhyloP100
-4.4
PrimateAI
Benign
0.23
T
PROVEAN
Benign
-0.11
N
REVEL
Benign
0.031
Sift
Benign
0.47
T
Sift4G
Benign
0.63
T
Polyphen
0.0010
B
Vest4
0.10
MPC
0.15
ClinPred
0.0067
T
GERP RS
-8.7
RBP_binding_hub_radar
1.0
RBP_regulation_power_radar
2.1
Varity_R
0.012
gMVP
0.13
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
2.0
SpliceAI score (max)
0.11
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35366573; hg19: chr1-207958446; COSMIC: COSV59731245; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.